Improving the Science of Measles Prevention—Will It Make for a Better Immunization Program?

English version České info

In a Perspective, Julie Garon and Walter Orenstein discuss Lessler and colleagues' modeling study on measles vaccination and the implications for triggered and routine immunization programs.

Vyšlo v časopise: Improving the Science of Measles Prevention—Will It Make for a Better Immunization Program?. PLoS Med 13(10): e32767. doi:10.1371/journal.pmed.1002145
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002145

Souhrn

In a Perspective, Julie Garon and Walter Orenstein discuss Lessler and colleagues' modeling study on measles vaccination and the implications for triggered and routine immunization programs.

Zdroje

1. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primer. 2016 Jul 14;2:16049.

2. WHO. Measles [Internet]. WHO. [cited 2016 Aug 8]. http://www.who.int/mediacentre/factsheets/fs286/en/

3. Thompson KM. Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis. Risk Anal Off Publ Soc Risk Anal. 2016 Jul;36(7):1383–403.

4. Moss WJ, Griffin DE. Measles. Lancet. 2012 Jan 14;379(9811):153–64. doi: 10.1016/S0140-6736(10)62352-5 21855993

5. World Health Organization. Measles vaccines: WHO position paper [Internet]. Geneva, Switzerland: World Health Organization; 2009 Aug [cited 2016 Aug 11] p. 349–60. (Weekly Epidemiologic Record). Report No.: 35. http://www.who.int/wer/2009/wer8435.pdf?ua=1

6. World Health Organization. Global measles and rubella strategic plan: 2012–2020. [Internet]. 2012 [cited 2016 Aug 2]. http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396%5Feng.pdf

7. World Health Organization. Response to measles outbreaks in measles mortality reduction settings. 2009 [cited 2016 Aug 2]; http://apps.who.int/iris/handle/10665/70047

8. Lessler J, Metcalf CJE, Cutts FT, Grenfell BT. (2016) Impact on epidemic measles of vaccination campaigns triggered by disease outbreaks or serosurveys: a modeling study. PLoS Med 13(10); e1002144.

9. Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis. 2004 May 1;189 Suppl 1:S17–22. 15106084

10. Atkinson WL, Orenstein WA, Krugman S. The resurgence of measles in the United States, 1989–1990. Annu Rev Med. 1992;43:451–63. 1580601

11. Orenstein WA. The role of measles elimination in development of a national immunization program. Pediatr Infect Dis J. 2006 Dec;25(12):1093–101. 17133153

12. Orenstein WA, Seib K. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination. Expert Rev Vaccines. 2016 Jul;15(7):791–3. doi: 10.1586/14760584.2016.1165614 26967373

13. Yang Y, Barraza L, Weidenaar K. Measles outbreak as a catalyst for stricter vaccine exemption legislation. JAMA. 2015 Sep 22;314(12):1229–30. doi: 10.1001/jama.2015.9579 26214397

14. Global Vaccine Action Plan 2011–2020 [Internet]. World Health Organization; 2013 [cited 2016 Aug 3]. http://www.who.int/iris/bitstream/10665/78141/1/9789241504980_eng.pdf?ua=1